CIK 0001665988 · Accelerated filer<br>Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810980861
- Phone
- (919) 474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Grant or award Director acquired 2,780,923 shares (grant or award)
- 8-K Event Results of operations · Regulation FD disclosure · Other events
- 4 Option exercise Director acquired 40,573 shares (option exercise)
- 4 Open-market sale SVP & General Counsel sold 16,016 shares at $11.19 ($179,238)
- 4 Open-market sale Chief Commercial Officer sold 65,963 shares at $11.12 ($733,502)
- 4 Option exercise Director acquired 2,700 shares (option exercise)
- 4 Option exercise Director acquired 2,700 shares (option exercise)
- 4 Option exercise Director acquired 2,700 shares (option exercise)
- 4 Open-market sale SVP & Chief Science Officer sold 32,997 shares at $11.17 ($368,425)
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 23,416 shares (option exercise)
- 4 Option exercise Director acquired 2,700 shares (option exercise)
- 8-K Event Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 3 Insider Initial Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 16 of 24 · 463 filings